Last year, the FDA approved the prescription drug Latisse for treatment of hypotrichosis. Hypotrichosis is a condition of abnormal hair growth, usually characterized by lack of hair where “normal” people grow hair. (Not to be confused with alopecia, which is characterized by the loss of hair where hair formerly existed.) For suffers nationwide, this meant the growth of fuller, thicker, longer hair in places they formerly had none - places that piqued the interest of beauty product lovers hoping to plump up their eyelashes.

In the clinical study, 78% of patients experienced remarkable increases in fullness, length and darker colored lashes. The drawbacks, because of course there are some, are as follows: Eye itching and eye redness are the most common side effects during the 16 week recommended use of the product. And most people we know experienced at least some of this during use. Increased pigmentation on the eye lids may not be permanent, but likely occurs during use. There is a risk for hair growth where ever the solution is applied (gross), but this can be prevented with proper application.

Anyway, there are a whole list of precautions, side effects, etc. that you can find here. Otherwise, it pretty much works wonders. Visit the Latisse website to see the before and after lash pics like that above from the 16 week trial study.

Digg      Del.icio.us     Technorati     Reddit     Tweet This
Share on Facebook